Publication ethics: Clinical and Experimental Ocular Trauma and Infection follows International Committee of Medical Journals Editors(ICMJE)Recommendations (http://www.icmje.org/recommendations/) and Committee on Publication Ethics (COPE) (https://publicationethics.org) international standards for editors and authors. All manuscripts submitted to Clinical and Experimental Ocular Trauma and Infection are screened for plagiarism using the ‘iThenticate’ software. Submitted manuscripts are also subjected for the evaluation of plagiarism, duplicate publication by automatic software. Authors are obliged to acknowledge if they published study results in full or in part in form of abstracts. Results indicating plagiarism may result in manuscripts being returned or rejected.
Plagiarism: To re-publish whole or in part the contents of another author's publication as one's own without providing a reference.
Fabrication: To publish data and findings/results that do not exist. Duplication: Use of data from another publication, which includes re-publishing a manuscript in different languages. Salamisation: To create more than one publication by dividing the results of a study preternaturally. We disapproval upon such unethical practices as plagiarism, fabrication, duplication, and salamisation, as well as efforts to influence the review process with such practices as gifting authorship, inappropriate acknowledgements, and references. Additionally, authors must respect participant right to privacy.
Experimental animal studies should be approved by animal ethic committee according to Guide for the Care and Use of Laboratory Animals (http://oacu.od.nih.gov/regs/guide/guide.pdf), clinical studies, clinical trials and new drug studies should be approved by ethical board. Approval reports sholud be submitted to the journal. Authors must declare that the study was conducted in accordance with international agreements and the Declaration of Helsinki.
The Clinical and Experimental Ocular Trauma and Infection is an independent international journal based on double-blind peer-review principles. The manuscript is assigned to the Editor-in-Chief, who reviews the manuscript and makes an initial decision based on manuscript quality and editorial priorities. Manuscripts that pass initial evaluation are sent for external peer review, and the Editor-in-Chief can evaluate the manuscripts himself/herself or can assign an Associate Editor. Then manuscripts are sent to at least two reviewers. The reviewers must review the manuscript within 12 weeks. The Associate Editor recommends a decision based on the reviewers’ recommendations and returns the manuscript to the Editor-in-Chief. The Editor-in-Chief makes a final decision based on editorial priorities, manuscript quality, and reviewer recommendations. If there are any conflicting recommendations from reviewers, the Editor-in-Chief can assign a new reviewer.
Author Responsibility Statement : The corresponding author and all co-authors affirm full responsibility for the submitted manuscript, including its text, tables, figures, and photographs. The authors declare that the work is original, accurate, and ethically compliant. All authors have reviewed and approved the final version of the manuscript prior to submission, and the corresponding author guarantees that all contributions are properly acknowledged and that the manuscript has been prepared in accordance with the journal’s requirements. The authors further guarantee that the manuscript text has not been generated by artificial intelligence tools, and that the photographs and figures included in the manuscript have not been created using artificial intelligence. All images are authentic and ethically obtained. Research involving human participants or animals has received appropriate ethical approval, and permissions for copyrighted materials have been secured. Any financial or personal conflicts of interest have been transparently disclosed.